Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sue Yu

A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients

BMC Musculoskeletal Disorders

English

Related publications

Modified-Release Prednisone for Polymyalgia Rheumatica: A Multicentre, Randomised, Active-Controlled, Double-Blind, Parallel-Group Study

English

Continuous Intrajejunal Infusion of Levodopa-Carbidopa Intestinal Gel for Patients With Advanced Parkinson's Disease: A Randomised, Controlled, Double-Blind, Double-Dummy Study

The Lancet Neurology

Neurology

2014

English

Cardiovascular Safety of Lumiracoxib: A Meta-Analysis of Randomised Controlled Trials in Patients With Osteoarthritis

European Journal of Clinical Pharmacology

Medicine

Pharmacology

2012

English

Incidence of Gastroduodenal Ulcers in Patients With Rheumatoid Arthritis After 12 Weeks of Rofecoxib, Naproxen, or Placebo: A Multicentre, Randomised, Double Blind Study

Gut

Gastroenterology

2003

English

A Double Blind, Multicentre, Placebo Controlled Trial of Lornoxicam in Patients With Osteoarthritis of the Hip and Knee.

Annals of the Rheumatic Diseases

English

The Effect of Omalizumab in Mastocytosis Patients. Prospective Double-Blind, Placebo-Controlled Multicentre Study

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Diclofenac Patch for Topical Treatment of Acute Impact Injuries: A Randomised, Double Blind, Placebo Controlled, Multicentre Study

British Journal of Sports Medicine

English

Randomised, Double-Blind, Placebo-Controlled Study of Olanzapine in Patients With Bipolar I Depression

British Journal of Psychiatry

English

Effect of Sulphasalazine in Patients With Active Crohn's Disease: A Controlled Double-Blind Study.

Gut

Gastroenterology

1981

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sue Yu

A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients

Related publications

Modified-Release Prednisone for Polymyalgia Rheumatica: A Multicentre, Randomised, Active-Controlled, Double-Blind, Parallel-Group Study

Continuous Intrajejunal Infusion of Levodopa-Carbidopa Intestinal Gel for Patients With Advanced Parkinson's Disease: A Randomised, Controlled, Double-Blind, Double-Dummy Study

Cardiovascular Safety of Lumiracoxib: A Meta-Analysis of Randomised Controlled Trials in Patients With Osteoarthritis

Incidence of Gastroduodenal Ulcers in Patients With Rheumatoid Arthritis After 12 Weeks of Rofecoxib, Naproxen, or Placebo: A Multicentre, Randomised, Double Blind Study

A Double Blind, Multicentre, Placebo Controlled Trial of Lornoxicam in Patients With Osteoarthritis of the Hip and Knee.

The Effect of Omalizumab in Mastocytosis Patients. Prospective Double-Blind, Placebo-Controlled Multicentre Study

Diclofenac Patch for Topical Treatment of Acute Impact Injuries: A Randomised, Double Blind, Placebo Controlled, Multicentre Study

Randomised, Double-Blind, Placebo-Controlled Study of Olanzapine in Patients With Bipolar I Depression

Effect of Sulphasalazine in Patients With Active Crohn's Disease: A Controlled Double-Blind Study.